News

New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...
This walking tour explores Shenzhen’s corporate landscape, developed for global firms and regional headquarters.
Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...
But more big tests loom with trade talks still continuing between the Trump administration and counterparts in China and the ...
Global consumption patterns are shifting and are driven by long-term changes in supply chains, pricing and consumer behaviour ...
Welcome to our live blog tracking the latest news and developments from Canada. Stay updated with real-time insights into the ...
GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric emptying - also have a range of other benefits.
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...
A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...
European stock markets are ripping. The numbers have surprised nearly everyone. During the first half of the year, European stocks outpaced their American peers by the widest margin on record (in U.S.